Clinical trial
VEGF Gene Transfer for Diabetic Neuropathy
NCT00056290 · Losordo, Douglas, M.D., Other · Completed
Key facts
| NCT number | NCT00056290 |
|---|---|
| Title | VEGF Gene Transfer for Diabetic Neuropathy |
| Official title | p.VGI.1 (VEGF2) Gene Transfer for Diabetic Neuropathy |
| Lead sponsor | Losordo, Douglas, M.D., Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Neuropathy |
| Intervention type | Biological |
| Interventions | VEGF |
| Enrollment | 60 |
| Start date | Dec 1, 2002 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Mar 11, 2003 |
| Last update posted | Nov 11, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: